Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diffusion Characteristics of LetibotulinumtoxinA vs OnabotulinumtoxinA and AbobotulinumtoxinA
2024-511047-26-01Phase 4Authorised
- Sponsor
- University of Hamburg
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in rhytides (3 arms), sponsored by University of Hamburg. Primary endpoint: Maximum anhidrosis area. Planned start Jun 2024; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on 2024-511047-26-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511047-26-01.